Urinary Concentration and Diluting Ability in Patients With Chronic Renal Disease and/ or Hypertension
NCT ID: NCT00313430
Last Updated: 2015-08-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2004-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Association Between Urine Concentration Ability and the Progression of Chronic Kidney Disease
NCT01423045
Orthostatic Hypotension and Blood Pressure Variability in Persons Undergoing Hemodialysis
NCT06348589
Prediction of Risk of Hypotension in Hemodialysis
NCT03350308
Evaluation of Total Blood Volume Measurement During Dialysis on the Incidence of Intradialytic Hypotension
NCT05872984
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
NCT06363097
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dialysis patients
No interventions assigned to this group
with or wthout glucose added to dialysis fluid
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Creatinine clearance between 30-59 ml/min
* Patients with hypertension, aged between 18 and 65, both men and women; hypertension is defined as a mean arterial blood pressure in the daytime that is more than 140/90 mm Hg.
* Healthy volunteers, aged between 18 and 65, both men and women
Exclusion Criteria
* Cancer
* Alcohol abuse
* Medicine abuse
* Pregnancy
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Erling Bjerregaard Pedersen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Erling Bjerregaard Pedersen
professor, chief physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Erling B Pedersen, Professor
Role: STUDY_CHAIR
Holstebro, Holstebro, Denmark
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Medicine, Holstebro Hospital
Holstebro, Ringkjoebing, Denmark
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Pedersen EB, Thomsen IM, Lauridsen TG. Abnormal function of the vasopressin-cyclic-AMP-aquaporin2 axis during urine concentrating and diluting in patients with reduced renal function. A case control study. BMC Nephrol. 2010 Oct 5;11:26. doi: 10.1186/1471-2369-11-26.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MED. RES.HOS 2004 03/IT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.